Hepatitis C virus infection upregulates expression of the type I interferon receptor in human peripheral blood mononuclear cells

Hepatology Research

Volumn 26, Issue 1, 2003, Pages 15-22

  Ren, Fenyu ^a   Hino, Keisuke ^a   Yamaguchi, Yuhki ^a   Okazaki, Muneko ^a   Kitase, Akira ^a   Satoh, Yasuhiro ^a   Korenaga, Masaaki ^a   Okuda, Michiari ^a   Okita, Kiwamu ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD4+ T cells; CD8+ T cells; HCV RNA; IFNAR1; IFNAR2; Interferon

Indexed keywords

ALPHA INTERFERON RECEPTOR; BETA INTERFERON RECEPTOR; CD4 ANTIGEN; CD8 ANTIGEN; HEPATITIS C ANTIBODY; INTERFERON; INTERFERON RECEPTOR; RECEPTOR SUBUNIT; RECOMBINANT GAMMA INTERFERON; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; FREQUENCY ANALYSIS; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MULTIPLE REGRESSION; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION;

EID: 0041590967     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(03)00004-4     Document Type: Article

References (36)

1. Weissmann C, Weber H. The interferon genes. Prog Nucleic Acid Res Mol Biol 1986;33:251-300.
2. Pestka S. The interferon receptors. Semin Oncol 1997;24(Suppl 9):s9-s18.
3. Domanski P, Colamonici OR. The type-I interferon receptor. The long and short of it. Cytokine Growth Factor Rev 1996;7:143-51.
4. Novick D, Cohen B, Rubinstein M. The human interferon α/β receptor: characterization and molecular cloning. Cell 1994;77:391-400.
5. Domanski P, Witte M, Kellum M, et al. Cloning and expression of a long form of the β subunit of the interferon αβ receptor that is required for signaling. J Biol Chem 1995;270:21606-11.
6. Lutfalla G, Holland SJ, Cinato E, et al. Mutant U5A cells are complemented by an interferon αβ receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO J 1995;14:5100-8.
7. Uzé G, Lutfalla G, Gresser I. Genetic transfer of a functional human interferon α receptor into mouse cells: cloning and expression of its cDNA. Cell 1990;60:225-34.
8. Mizukoshi E, Kaneko S, Yanagi M, et al. Expression of interferon alpha/beta receptor in the liver of chronic hepatitis C patients. J Med Virol 1998;56:217-23.
9. Yatsuhashi H, Fujino T, Matsumoto T, Inoue O, Koga M, Yano M. Immunohistochemical analysis of hepatic interferon alpha-beta receptor level: relationship between receptor expression and response to interferon therapy in patients with chronic hepatitis C. J Hepatol 1999;30:995-1003.
10. Mizukoshi E, Kaneko S, Kaji K, et al. Serum level of soluble interferon alpha/beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis. Hepatology 1999;30:1325-31.
11. Mizukoshi E, Kaneko S, Yanagi M, Ohno H, Matsushita E, Kobayashi K. Upregulation of type I interferon receptor by IFN-γ. J Interferon Cytokine Res 1999;19:1019-23.
12. + T cells in chronic hepatitis C virus infection. Am J Gastroenterol 2000;95:227-32.
13. + T cells with memory-phenotype in patients with chronic hepatitis C. J Med Virol 2002;67:162-70.
14. Wang JT, Sheu JC, Lin JT, Wang TH, Chen DC. Detection of replicative form hepatitis C virus RNA in peripheral blood mononuclear cells. J Infect Dis 1992;166:1167-9.
15. Muller HM, Pfaff E, Goeser T, Kallinwski B, Solbach C, Thielman L. Peripheral blood mononuclear leukocytes serve as a possible extrahepatic site of hepatitis C virus replication. J Gen Virol 1997;4:669-76.
16. Moldvay BJ, Deny P, Pol S, Brechot C, Lamas E. Detection of hepatitis C virus RNA in peripheral blood mononuclear cells of infected patients by in situ hybridization. Blood 1994;83:269-73.
17. Lerat H, Berby F, Trabaud MA, Vidalin O, Major M, Trepo C. Specific detection of hepatitis C virus strand RNA in hematopoietic cells. J Clin Invest 1996;97:845-51.
18. Okuda M, Hino K, Korenaga M, Yamaguchi Y, Katoh Y, Okita K. Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells and liver. Hepatology 1999;29:217-22.
19. Fukuda R, Ishimura N, Kushiyama Y, et al. Effectiveness of interferon-alfa therapy in chronic hepatitis C is associated with the amount of interferon-alfa receptor mRNA in the liver. J Hepatol 1997;26:455-61.
20. Yatsuhashi H, Yamasaki K, Aritomi T, et al. Quantitative analysis of interferon α/β receptor mRNA in the liver of patients with chronic hepatitis C: correlation with serum hepatitis C virus-RNA levels and response to treatment with interferon. J Gastroenterol Hepatol 1997;12:460-7.
21. Morita K, Tanaka K, Saito S, et al. Expression of interferon receptor genes (IFNAR1 and IFNAR2 mRNA) in the liver may predict outcome after interferon therapy in patients with chronic genotype 2a or 2b hepatitis C virus infection. J Clin Gastroenterol 1998;26:135-40.
22. Mathai J, Shimoda K, Banner BF, Mori M, Bonkovsky HL, Barnard GF. IFN-alpha receptor mRNA expression in a United States sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy. J Interferon Cytokine Res 1999;19:1011-8.
23. Morita K, Tanaka K, Saito S, et al. Expression of interferon receptor genes in the liver as a predictor of interferon response in patients with chronic hepatitis C. J Med Virol 1999;58:359-65.
24. Poynard T, Bedossa P. METAVIR and CLINIVIR cooperative study groups. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. J Viral Hepat 1997;4:199-208.
25. Ono E, Shiratori Y, Okudaira T, et al. Platelet count reflects stage of chronic hepatitis C. Hepatol Res 1999;15:192-200.
26. Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673-9.
27. Hino K, Okuda M, Konishi T, Ishiko H, Okita K. Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-α therapy. Dig Dis Sci 1995;40:14-20.
28. Tanaka T, Tsukiyama-Kohara K, Yamaguchi K, et al. Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology 1994;19:1347-53.
29. Simmonds P, Alberti A, Alter HJ, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994;19:1321-4.
30. Cutrone EC, Langer JA. Contribution of cloned type I interferon receptor subunits to differential ligand binding. FEBS Lett 1997;404:197-202.
31. Chuntharapai A, Gibbs V, Li J, et al. Determination of residues involved in ligand binding and signal transmission in the human IFN-α receptor 2. J Immunol 1999;163:766-73.
32. Kondo M, Nagano H, Sakon M, et al. Expression of interferon alpha/beta receptor in human hepatocellular carcinoma. Int J Oncol 2000;17:83-8.
33. Plett PA, Gardner EM, Murasko DM. Age-related changes in interferon alpha/beta receptor expression, binding, and induction of apoptosis in natural killer cells from C57BL/6 mice. Mech Aging Dev 2000;118:129-44.
34. Yamaguchi Y, Hino K, Fujiwara D, et al. Expression of type I interferon receptor in liver and peripheral blood mononuclear cells in chronic hepatitis C patients. Disg Dis Sci 2002;47:1611-7.
35. Iwata K, Wakita T, Okumura A, et al. Interferon gamma production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection. Hepatology 1995;22:1057-64.
36. Lau JNY, Sheron N, Morris AG, Bomford AB, Alexander GJM, Williams R. Interferon-α receptor expression and regulation in chronic hepatitis B virus infection. Hepatology 1991;13:332-8.